Next Article in Journal
Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients
Previous Article in Journal
Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(7), 902; https://doi.org/10.3390/ph17070902
Action Date Notes Link
article xml file uploaded 7 July 2024 07:57 CEST Original file -
article xml uploaded. 7 July 2024 07:57 CEST Update https://www.mdpi.com/1424-8247/17/7/902/xml
article pdf uploaded. 7 July 2024 07:57 CEST Version of Record https://www.mdpi.com/1424-8247/17/7/902/pdf
article supplementary file uploaded. 7 July 2024 07:57 CEST - https://www.mdpi.com/1424-8247/17/7/902#supplementary
article html file updated 7 July 2024 07:59 CEST Original file https://www.mdpi.com/1424-8247/17/7/902/html
Back to TopTop